A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.
Rouwendal GJ, van der Lee MM, Meyer S, Reiding KR, Schouten J, de Roo G, Egging DF, Leusen JH, Boross P, Wuhrer M, Verheijden GF, Dokter WH, Timmers M, Ubink R.
Rouwendal GJ, et al. Among authors: leusen jh.
MAbs. 2016;8(1):74-86. doi: 10.1080/19420862.2015.1102812. Epub 2015 Oct 6.
MAbs. 2016.
PMID: 26440530
Free PMC article.